1. Home
  2. STX vs EW Comparison

STX vs EW Comparison

Compare STX & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STX
  • EW
  • Stock Information
  • Founded
  • STX 1978
  • EW 1958
  • Country
  • STX Singapore
  • EW United States
  • Employees
  • STX N/A
  • EW N/A
  • Industry
  • STX Electronic Components
  • EW Industrial Specialties
  • Sector
  • STX Technology
  • EW Health Care
  • Exchange
  • STX Nasdaq
  • EW Nasdaq
  • Market Cap
  • STX 46.3B
  • EW 45.5B
  • IPO Year
  • STX 2002
  • EW 2000
  • Fundamental
  • Price
  • STX $224.59
  • EW $75.73
  • Analyst Decision
  • STX Buy
  • EW Buy
  • Analyst Count
  • STX 20
  • EW 18
  • Target Price
  • STX $184.05
  • EW $86.29
  • AVG Volume (30 Days)
  • STX 5.0M
  • EW 4.9M
  • Earning Date
  • STX 10-29-2025
  • EW 10-23-2025
  • Dividend Yield
  • STX 1.28%
  • EW N/A
  • EPS Growth
  • STX 328.48
  • EW 188.09
  • EPS
  • STX 6.77
  • EW 7.02
  • Revenue
  • STX $9,097,000,000.00
  • EW $5,685,100,000.00
  • Revenue This Year
  • STX $16.54
  • EW $13.23
  • Revenue Next Year
  • STX $9.96
  • EW $9.76
  • P/E Ratio
  • STX $33.13
  • EW $10.73
  • Revenue Growth
  • STX 38.86
  • EW 9.14
  • 52 Week Low
  • STX $63.19
  • EW $64.51
  • 52 Week High
  • STX $264.83
  • EW $83.00
  • Technical
  • Relative Strength Index (RSI)
  • STX 57.92
  • EW 39.74
  • Support Level
  • STX $223.01
  • EW $76.48
  • Resistance Level
  • STX $264.83
  • EW $78.04
  • Average True Range (ATR)
  • STX 11.05
  • EW 1.77
  • MACD
  • STX -1.93
  • EW 0.13
  • Stochastic Oscillator
  • STX 26.38
  • EW 37.30

About STX Seagate Technology Holdings PLC (Ireland)

Seagate Technology is a leading supplier of hard disk drives for data storage to the enterprise and consumer markets. It forms a practical duopoly in the market with its chief rival, Western Digital; they are both vertically integrated.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: